International Biotechnology Trust PLC Corvus Pharmaceuticals, Inc. Transaction History

International Biotechnology Trust PLC

  • $295 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$3.29 - $8.94 $355,320 - $965,520
-108,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$8.58 - $11.4 $926,640 - $1.23 Million
108,000 New
108,000 $710,000
Q3 2018

Nov 13, 2018
SELL
$8.58 - $11.4 $697,905 - $927,287
-81,341 Closed
0 $0
Q2 2018

Aug 13, 2018
BUY
$9.42 - $13.73 $766,232 - $1.12 Million
81,341 New
81,341 $892,000

Others Institutions Holding CRVS

# of Institutions
73
Shares Held
30.4M
Call Options Held
1.06M
Put Options Held
84.3K
View Full List

About Corvus Pharmaceuticals, Inc.

CRVS Quotes by TradingView
  • Ticker CRVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,553,500
  • Market Cap $223M
  • Description
  • Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...
More about CRVS
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email